Collection and analysis of real-time data about Fibrolamellar aim to deliver essential information for doctors and patients about this rare form of liver cancer Today, xCures announced their collaboration with the FibroFighters Foundation to launch a real-time learning platform for the Fibrolamellar Hepatocellular Carcinoma (FLHCC) community. FLHCC is a rare … Continue reading xCures partners with FibroFighters to launch a real-time learning platform for Fibrolamellar Hepatocellular Carcinoma